Gilead Sciences GILD
CEO: Daniel O'Day · Biotechnology · 17,000 employees
A
Pay-for-Performance
88/100
$9.2M
CEO Total Comp
243:1
CEO-Worker Ratio
91.5%
Say-on-Pay Vote
+50.6%
3yr TSR
$38K
Median Worker Pay
Compensation Breakdown
Salary$824K
Stock Awards$4.6M
Options$2.5M
Non-Equity Incentive$1.3M
Other$41K
Compensation History
| Year | Salary | Bonus | Stock Awards | Options | Non-Equity | Other | Total |
|---|---|---|---|---|---|---|---|
| 2025 | $824K | — | $4.6M | $2.5M | $1.3M | $41K | $9.2M |
| 2024 | $808K | — | $6.1M | $1.2M | $1.8M | $193K | $10.0M |
| 2023 | $791K | $103K | $3.6M | $2.7M | $626K | $139K | $8.2M |
| 2022 | $775K | — | $5.8M | $711K | $862K | $197K | $8.6M |